Opportunity Information: Apply for PA 07 011
Apply for PA 07 011
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Erythroid Lineage Molecular Toolbox (R01)" and is now available to receive applicants.
- This funding opportunity was created on May 28, 2009 and posted on Nov 20, 2006.
- Applicants must submit their applications by Sep 7, 2009 Multiple Receipt Dates See Link to Full Announcement for details.. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: For profit organizations other than small businesses City or township governments Special district governments Public housing authorities/Indian housing authorities Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) Public and State controlled institutions of higher education Private institutions of higher education County governments Small businesses State governments Independent school districts Others (see text field entitled Additional Information on Eligibility for clarification) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Native American tribal governments (Federally recognized).
- Foreign institutions are eligible to apply. Eligible agencies of the Federal Government can apply. Faith based or community based organizations can apply.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Erythroid Lineage Molecular Toolbox (R01) funding opportunity (PA 07 011) is an NIH grant program from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) focused on accelerating research on erythroid cells, meaning the cellular lineage that produces red blood cells. The central goal is to build a more complete and usable "molecular toolbox" for the field by supporting projects that identify, characterize, and organize the key molecular components that are expressed in erythroid cells across development and differentiation. In practice, this includes mapping which genes are turned on in erythroid cells at different stages, as well as defining the proteins those genes produce, including protein features that may be especially important in erythroid biology such as post-translational modifications and erythroid-specific subcellular localization.
A major theme of the opportunity is moving beyond lists of genes and proteins toward resources that help connect genetics to function. NIDDK frames a long-range objective of unifying genetic information with biological outcomes by enabling researchers to link gene and protein structure-function relationships to erythroid cell morphology, physiology, and disease phenotypes. That emphasis points to practical downstream value: better tools and datasets should make it easier to interpret how variants or perturbations in erythroid-expressed genes translate into changes in red cell development or function, and ultimately into clinically relevant disorders.
The FOA also explicitly encourages the creation of reagents and enabling resources that the broader research community can use to study erythroid lineages. While the announcement does not prescribe a single type of reagent, the intent is clear: support the development of tangible tools that make erythroid biology easier to interrogate, whether that involves molecular constructs, antibodies, tagged proteins, standardized assays, curated expression datasets, or other broadly applicable community resources. Alongside reagent development, NIDDK welcomes new technologies that help researchers apply genomic and molecular information in erythroid systems, signaling that methodological innovation is in scope when it directly improves the ability to study erythroid gene/protein expression and function.
Applicants are encouraged to align with and leverage existing NIDDK-supported resources, specifically referencing the Progenitor Cell Genome Anatomy Projects and directing investigators to http://www.scgap.org for current assets. The announcement highlights that synergy with those ongoing projects is desirable, suggesting that proposed work that complements, extends, or interoperates with existing progenitor cell and genome anatomy efforts may be particularly responsive to program goals.
In terms of funding mechanism, this is an NIH Research Project Grant (R01) opportunity, intended for more mature, hypothesis-driven or resource-building projects that can be executed at full R01 scope. NIDDK notes that it runs in parallel with a separate announcement of identical scientific scope using the R21 exploratory/developmental mechanism (PA 06 170), which effectively provides two entry points: R01 for more established projects and R21 for earlier-stage, high-risk/high-reward or proof-of-concept work.
Budget size, project period, and the number of awards are not fixed in advance. NIDDK states that awards will vary depending on the nature and scope of proposed research, and that the total number of awards and total dollars will depend on the volume, quality, duration, and costs of the applications received. This is typical language for NIH program announcements where the institute wants flexibility to fund the most compelling proposals without committing to a predetermined award count.
Eligibility is broad. A wide range of domestic applicant organizations may apply, including for-profit organizations (including small businesses), nonprofits (with or without 501(c)(3) status), public and private institutions of higher education, and various levels of government (state, county, city/township, special districts, independent school districts), as well as tribal organizations and tribal governments. The opportunity also states that foreign institutions are eligible to apply, that eligible federal agencies can apply, and that faith-based or community-based organizations may apply, which further expands the pool of potential applicants.
Administratively, the program was posted on November 20, 2006, with multiple receipt dates (rather than a single deadline), and it is now archived (archive date October 8, 2009), meaning it is not an active, open solicitation today but remains important as a historical reference for the kind of erythroid resource-building and molecular characterization work NIDDK sought to fund. The full announcement was made available through the NIH grants guide (historically at grants.nih.gov), and NIH provided standard support contacts through the Office of Extramural Research for access or linking issues.
Frequently Asked Questions (FAQs)
What is the Erythroid Lineage Molecular Toolbox (R01) funding opportunity?
The Erythroid Lineage Molecular Toolbox (R01) is an NIH Research Project Grant (R01) funding opportunity (PA-07-011) from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). It supports research projects aimed at building a more complete and usable set of molecular resources ("molecular toolbox") for studying erythroid cells, the lineage that produces red blood cells.
Which NIH Institute runs this program?
This funding opportunity is run by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), an institute within the NIH.
What is the main scientific focus of this FOA?
The FOA focuses on accelerating research on erythroid biology by supporting projects that identify, characterize, and organize key molecular components expressed in erythroid cells across development and differentiation.
What does "erythroid lineage" mean in this context?
In this FOA, "erythroid lineage" refers to the cellular lineage responsible for producing red blood cells, including stages of erythroid development and differentiation.
What is meant by a "molecular toolbox" for erythroid cells?
A "molecular toolbox" refers to organized, usable resources for the field that go beyond raw lists of genes and proteins. The goal is to provide tools, datasets, and reagents that help researchers understand what is expressed in erythroid cells, when it is expressed during development/differentiation, and how those molecular components relate to function and disease phenotypes.
What types of research activities are explicitly highlighted as in scope?
The FOA highlights work such as mapping gene expression across erythroid stages, defining the proteins produced from those genes, and characterizing protein features important to erythroid biology. Examples called out include post-translational modifications and erythroid-specific subcellular localization.
Does the FOA emphasize functional interpretation or only cataloging genes/proteins?
The FOA emphasizes moving beyond catalogs. A major theme is developing resources that help connect genetic information to biological function, including linking gene and protein structure-function relationships to erythroid cell morphology, physiology, and disease phenotypes.
How does this program aim to connect genetics to erythroid biology and disease?
NIDDK describes a long-range objective of unifying genetic information with biological outcomes. The intent is that improved tools and datasets will help researchers interpret how variants or perturbations in erythroid-expressed genes translate into changes in red cell development or function, and ultimately into clinically relevant disorders.
Are reagent and community resource development encouraged?
Yes. The FOA explicitly encourages the creation of reagents and enabling resources that the broader research community can use to study erythroid lineages.
What kinds of reagents or enabling resources are contemplated?
The FOA does not require a single reagent type, but it signals broad interest in tangible tools such as molecular constructs, antibodies, tagged proteins, standardized assays, curated expression datasets, and other broadly applicable community resources that make erythroid biology easier to study.
Are new technologies or methodological innovations allowed under this FOA?
Yes. NIDDK welcomes new technologies that help researchers apply genomic and molecular information in erythroid systems, particularly when the innovation directly improves the ability to study erythroid gene/protein expression and function.
Does the FOA encourage leveraging existing NIDDK-supported resources?
Yes. Applicants are encouraged to align with and leverage existing NIDDK-supported resources, specifically referencing the Progenitor Cell Genome Anatomy Projects.
Where does the FOA direct applicants for related existing assets?
The FOA references the Progenitor Cell Genome Anatomy Projects and points investigators to http://www.scgap.org for current assets.
Is synergy with the Progenitor Cell Genome Anatomy Projects considered desirable?
Yes. The announcement indicates that synergy with those ongoing projects is desirable, suggesting that proposed work that complements, extends, or interoperates with existing progenitor cell and genome anatomy efforts may be particularly responsive to program goals.
What funding mechanism is used for this opportunity?
This is an NIH Research Project Grant (R01) funding opportunity, intended for full-scope research or resource-building projects.
Is there a related opportunity using a different NIH mechanism?
Yes. NIDDK notes a parallel announcement of identical scientific scope using the R21 exploratory/developmental mechanism (PA-06-170), creating two entry points: R01 for more established efforts and R21 for earlier-stage exploratory work.
Does the FOA specify a fixed budget size, project period, or number of awards?
No. The FOA states that budget size, project period, and number of awards are not fixed in advance and will vary based on the nature and scope of the proposed research. Total awards and total dollars depend on the volume, quality, duration, and costs of applications received.
Who is eligible to apply?
Eligibility is broad and includes many domestic organization types such as for-profit organizations (including small businesses), nonprofits (with or without 501(c)(3) status), public and private institutions of higher education, and multiple levels of government entities. The FOA also includes tribal organizations and tribal governments, faith-based or community-based organizations, eligible federal agencies, and foreign institutions.
Are for-profit organizations allowed to apply?
Yes. For-profit organizations, including small businesses, are listed as eligible applicants.
Are nonprofit organizations required to have 501(c)(3) status to apply?
No. The FOA states that nonprofit organizations with or without 501(c)(3) status may apply.
Are higher education institutions eligible?
Yes. Both public and private institutions of higher education are eligible to apply.
Are government entities eligible applicants?
Yes. The FOA includes various government entities such as state, county, city/township governments, special districts, independent school districts, and eligible federal agencies.
Are tribal organizations and tribal governments eligible?
Yes. Tribal organizations and tribal governments are listed among eligible applicants.
Are faith-based or community-based organizations eligible?
Yes. The FOA states that faith-based or community-based organizations may apply.
Are foreign institutions eligible to apply?
Yes. The opportunity states that foreign institutions are eligible to apply.
When was this opportunity posted and what is its current status?
The program was posted on November 20, 2006. It is archived (archive date October 8, 2009), meaning it is not an active, open solicitation today and primarily serves as a historical reference for the program goals and the types of projects NIDDK sought to support.
Did this FOA have one deadline or multiple receipt dates?
The FOA had multiple receipt dates rather than a single deadline.
Where was the full announcement historically made available?
The full announcement was made available through the NIH Grants Guide (historically at grants.nih.gov).
What support did NIH provide for access or linking issues related to the announcement?
NIH provided standard support contacts through the Office of Extramural Research for access or linking issues.
Browse more opportunities from the same category: Health
Next opportunity: Research on Improving Health Care for Obese Patients (R01)
Previous opportunity: Research Project Grant (Parent R01)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PA 07 011
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (PA 07 011) also looked into and applied for these:
| Funding Opportunity |
|---|
| Research on Alcohol and HIV/AIDS (R01) Apply for PA 07 028 Funding Number: PA 07 028 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Research on Alcohol and HIV/AIDS (R21) Apply for PA 07 063 Funding Number: PA 07 063 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Research on Alcohol and HIV/AIDS (R03) Apply for PA 07 064 Funding Number: PA 07 064 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Alcohol Use Disorders Treatment, Services Research, and Recovery (R01) Apply for PA 07 066 Funding Number: PA 07 066 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Basic and Clinical Studies of Congenital Urinary Tract Obstruction (R01) Apply for PA 07 059 Funding Number: PA 07 059 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Insulin Signaling And Receptor Cross Talk (R01) Apply for PA 07 058 Funding Number: PA 07 058 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Right Heart Function in Health and Chronic Lung Diseases (R01) Apply for PA 07 043 Funding Number: PA 07 043 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Research on Mild and/or Unilateral Hearing Loss (R01) Apply for PA 07 038 Funding Number: PA 07 038 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Ancillary Studies of Kidney Disease Accessing Information from Clinical Trials, Epidemiological Studies, and Databases (R01) Apply for PA 07 050 Funding Number: PA 07 050 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Calcium Oxalate Stone Diseases (R01) Apply for PA 07 051 Funding Number: PA 07 051 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Pancreatic Development and Regeneration Toward Cellular Therapies for Diabetes (R01) Apply for PA 07 056 Funding Number: PA 07 056 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Research On Adherence To Interventions For Mental Disorders (R01) Apply for PA 07 076 Funding Number: PA 07 076 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Pathophysiology and Treatment Response in Late Life Mood and Anxiety Disorders (R01) Apply for PA 07 077 Funding Number: PA 07 077 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Indo U.S. Vaccine Action Program (VAP) Small Research Grant Program (R03) Apply for PA 07 093 Funding Number: PA 07 093 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Effectiveness, Practice, And Implementation In CMHS Comprehensive Community Mental Health Services Program for Children and their Families Service Sites (R01) Apply for PA 07 091 Funding Number: PA 07 091 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| The Central Processing of Taste Information (R01) Apply for PA 07 094 Funding Number: PA 07 094 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIDCD Patient Oriented Research Grant (R01) Apply for PA 07 095 Funding Number: PA 07 095 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Targeting Calcium Regulatory Molecules for Arrhythmia Prevention (R01) Apply for PA 07 101 Funding Number: PA 07 101 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Elucidating Nature s Solutions to Heart, Lung, and Blood Diseases and Sleep Disorder Processes (R01) Apply for PAR 07 102 Funding Number: PAR 07 102 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Research Opportunities in Stuttering (R01) Apply for PA 07 124 Funding Number: PA 07 124 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants

Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PA 07 011", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
